The President-elect said his team plans to "manage the hell out of this operation," to hit the ground running on vaccinating Americans.
1
It's “a full-frontal assault on public health," one official said.
1
Dr. David Kessler has worked closely alongside President-elect Joe Biden as an advisor to his transition team on COVID-19.
6
Action plan to regulate machine-learning software in 2021 revealed The US Food and Drug Administration wants manufacturers to specifically label AI-powered medical devices to help patients understand the technology, and to test them on real-world data to see how they perform in the wild beyond clinical environments.…
9
KD Market Insights (KDMI) recently published market research report on the Global Healthcare Robotics market, this market research report provides detailed analysis of market drivers, challenges, opportunity analysis, and trends, along with various key insights into the market research report.The study also includes the analysis of the market size & forecast for the different segments and geographies.The global Healthcare Robotics market is anticipated to reach at a notable value by the end of 2025.In the past years, the market has grown at a significant rate and is projected to showcase a lucrative growth in the upcoming years.Get sample [email protected]  https://www.kdmarketinsights.com/sample/6821The growth of this market is attributed towards major relying factors including increasing automation technologies, increase in funding and investment for medical robot research and market, the issuance of IPOs by medical robot companies, patient preference for minimally invasive surgeries, growth in the geriatric population, growing disabilities in humans, supply shortage of medical professionals, Food and Drug Administration (FDA) approval of critical surgeries and government backing for the healthcare market.The study for global Healthcare Robotics market covers the key market growth indicators such as value and supply chain analysis, year-on-year (Y-o-Y) growth and compounded annual growth rate (CAGR), in the KDMI’s research report along with macroeconomic indicators & forecast factors.Also, the analysis of Porter’s Five Forces demonstrates the five forces which include buyers bargaining power, suppliers bargaining power, the threat of new entrants, the threat of substitutes, and degree of competition in the global Healthcare Robotics market.Impact of Coronavirus Disease (COVID-19) on Global Healthcare Robotics MarketThe coronavirus or COVID-19 (formerly 2019-nCoV) broke out in December 2019, which has been imposed as a medical emergency worldwide.The study explains the impact of coronavirus disease (COVID-19) on global Healthcare Robotics market, covering the following points:- Impact analysis of COVID-19 on the global Healthcare Robotics market in the upcoming years.- Detailed research regarding each region & countries will be listed, to identify the issues caused by the coronavirus disease on the market.- Strategies adopted by the major & prominent market players in order to survive in the situation of COVID-19 lockdown.Get Complete Research Report with [email protected] https://www.kdmarketinsights.com/product/6821/healthcare-robotics-marketKey Insights Covered in the Global Healthcare Robotics Market ReportAnalysis of market including the market forecast, Y-o-Y growth and structure of the industry.Leading market growth factors, market trends and upcoming opportunities driving the growth of the market.Identifying the barriers & threats hindering the market growth.Detailed analysis of major & prominent players in the market & also covering a comprehensive analysis of the company’s business and performance.Various market activities covering the market research report including product launch, innovation, acquisition, expansion, technological advancement, research & development & other market activities.Segment OutlookThe global Healthcare Robotics market is segmented (By Product, By Application and By End User).This market research report offers comprehensive data and information about the global Healthcare Robotics market dynamics & growth parameters related to these categories.
 To order this detailed 280+ page report, please visit this link Key InclusionsA detailed assessment of the current market landscape, featuring a comprehensive list of over 90 CROs that offer in vitro ADME testing services, and analyses based on a number of parameters, such as year of establishment, headquarter location(s), company size, type of additional service(s) offered (in vivo ADME, in silico ADME and toxicology testing), range of assays offered within in vitro ADME service portfolio (blood to plasma ratio, Caco-2 permeability, cytochrome (CYP) enzyme induction / inhibition, metabolic stability, plasma protein binding, reaction phenotyping and others), type of molecule(s) (biologics and small molecules), and type of clientele (pharmaceutical / biotechnology companies and academic / research institutes).A schematic logo landscape of in vitro ADME service providers, highlighting their geographical distribution (on the basis of location of headquarters) and company size (small-sized (1-50 employees), mid-sized (51-200 employees), large (201-1,000 employees), and very large (>1,000 employees)).A discussion on the various outsourcing business models adopted in this domain, along with a list of key considerations that need to be taken into account by industry stakeholders while selecting a CRO partner.Elaborate profiles of popular in vitro ADME testing service providers, featuring a brief overview of the company, its financial information (if available), information on in vitro ADME service(s) capabilities, and a comprehensive future outlook.A comprehensive benchmark analysis, highlighting the key focus areas of small, mid-sized and large companies, comparing their existing capabilities within and beyond their respective peer groups, and thereby, providing a means for stakeholders to identify ways to gain a competitive edge in the industry.A detailed analysis of the various mergers and acquisitions that have taken place in this domain, highlighting the trend in the number of companies acquired between 2005-2018, along with the geographical distribution of this activity.The analysis also features an ownership change matrix, providing a summary of the involvement of private and public sector entities in this domain.A detailed discussion on the various regulatory guidelines related to in vitro ADME testing, which have been laid down by major international / regional regulatory bodies (namely European Medicine Agency (EMA), US Food and Drug Administration (USFDA), Ministry of Health, Labor and Welfare (MHLW), International Council for Harmonisation (ICH) of Technical Requirements for Pharmaceuticals for Human Use, the Organization for Economic Co-operation and Development (OECD), and World Health Organization (WHO)).The report also features the likely distribution of the current and forecasted opportunity across important market segments, mentioned below: Type of MoleculeSmall MoleculesBiologics Type of ServiceAbsorption TestingDistribution TestingMetabolism and Elimination Testing Type of AssayCaco-2 Permeability AssayPAMPA Permeability AssayMDCK Permeability AssayProtein Binding AssayBlood Brain Barrier AssayBlood to Plasma RatioStability / Clearance AssayEnzyme Induction AssayEnzyme Inhibition AssayMetabolite Profiling and Screening / Identification AssayMetabolite Production AssayReaction Phenotyping AssayTransporter Interactions Assay Target Therapeutic AreaBlood DisordersCardiovascular DisordersGastrointestinal and Digestive DisordersHormonal DisordersInfectious DiseasesImmunological DisordersMetabolic DisordersMental DisordersNeurological DisordersOncological DisordersRespiratory DisordersSkin DisordersUrogenital DisordersOthers Type of SponsorIndustry PlayersNon-Industry Players Key Geographical RegionsNorth AmericaEuropeAsia-Pacific and Rest of the World The report includes detailed transcripts of discussions held with the following experts:Dan Close (Chief Scientific Officer, 490 Bio Tech)Sridhar Iyer (Director and Global Head, Business Development, JRF Global) and Sarang Gorte (Assistant Manager, Business Development, JRF Global) To request sample pages, please visit this link Key Questions AnsweredWho are the leading CROs offering in vitro ADME testing services?What are the key services being offered by in vitro ADME testing service providers?What is the trend of mergers and acquisitions in this domain?How is the current and future market opportunity likely to be distributed across key market segments?What are the anticipated future trends related to in vitro ADME testing services market?You may also be interested in the following titles:In Silico / Computer-Aided Drug Discovery Services Market: Focus on Large Molecules, 2020-2030AR / VR based Healthcare Digital Marketing Service Providers Market, 2020-2030Bioavailability Enhancement Technologies and Services Market, 2020-2030 Contact UsGaurav Chaudhary+1 (415) 800 [email protected]
Roots Analysis has announced the addition of “In Vitro ADME Testing Services Market, 2019-2030” report to its list of offerings.According to the US Food and Drug Administration (USFDA), less than 10% of investigational new drug (IND) candidates progress beyond the submission of a new drug application (NDA); this implies that majority of the drug / therapy candidates fail to reach the market owing to unacceptable safety and efficacy profiles and the problems associated with their pharmacokinetic profiles, ADME properties and inherent toxicity.To order this 280+ page report, which features 135+ figures and 120+ tables, please visit this  link Key Market Insights  Nearly 100 players currently claim to provide in vitro ADME testing servicesNearly 60% of these companies are small and mid-sized firms.Further, close to 35% of the CROs engaged in this domain, claim to provide services to both pharmaceutical companies and academic institutes.Over 85% companies claim to offer assays for drug metabolism and elimination testing Further, nearly 70% companies claim to have capabilities to conduct absorption and distribution related studies, respectively.It is worth mentioning that about 35% of players presently offer end-to-end drug discovery services.
Roots Analysis has announced the addition of “In Vitro ADME Testing Services Market, 2019-2030” report to its list of offerings.According to the US Food and Drug Administration (USFDA), less than 10% of investigational new drug (IND) candidates progress beyond the submission of a new drug application (NDA); this implies that majority of the drug / therapy candidates fail to reach the market owing to unacceptable safety and efficacy profiles and the problems associated with their pharmacokinetic profiles, ADME properties and inherent toxicity.To order this 280+ page report, which features 135+ figures and 120+ tables, please visit this  link Key Market Insights  Nearly 100 players currently claim to provide in vitro ADME testing servicesNearly 60% of these companies are small and mid-sized firms.Further, close to 35% of the CROs engaged in this domain, claim to provide services to both pharmaceutical companies and academic institutes.Over 85% companies claim to offer assays for drug metabolism and elimination testing Further, nearly 70% companies claim to have capabilities to conduct absorption and distribution related studies, respectively.It is worth mentioning that about 35% of players presently offer end-to-end drug discovery services.
Midwestern Pet Company issued a voluntary recall after the food was found to have dangerous levels of aflatoxins, which are produced by mold.
8
Summary – A New Market Study, “Canine Leishmaniasis Management Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012 to 2016 and Forecast 2017 to 2023” Has Been Featured On Wiseguyreports.Global Canine Leishmaniasis Management Market Canine leishmaniasis is a vector-borne disease caused by the Leishmania infantum and Leishmania chagasi.The severity of the canine leishmaniasis leads to the death of animals and high risk of disease transmission in humans and other dogs.The canine leishmaniasis can be prevented by administering the vaccines initially 3 doses with 3-week interval between them and an annual dose which increase the immunity in the canines.Also Read : https://icrowdnewswire.com/2021/01/06/canine-leishmaniasis-management-market-segmentation-application-trends-opportunity-amp-forecast-2021-to-2023/The canine leishmaniasis management market is growing at a significant CAGR due to increase in adoption of canines.However, stringent regulatory policies for the approval of new vaccines for the canine leishmaniasis management, storage of vaccines, lack of awareness regarding canine leishmaniasis management, increase in the canine culling process, and dearth of canine leishmaniasis management products in the market might hamper the canine leishmaniasis management market growth in the forecast years.Also Read : http://www.marketwatch.com/story/global-pharmaceutical-waste-management-market-2020-demand-expeditious-growth-trends-segmentation-and-forecast-to-2026-2020-11-06Canine leishmaniasis management market is segmented on the basis of product type, disease type, route of administration, and end user Based on the product type, canine leishmaniasis management market is segmented into the following:Canine leishmaniasis preventionVaccinesCanine leishmaniasis treatmentAntibioticsPolyene antibiotics (Amphotericin B)MarbofloxacinOthersMiltefosineMeglumine antimoniatePentavalent antimonialsAllopurinol combinationsParomomycinOthersAlso Read : http://www.marketwatch.com/story/global-frozen-cheese-market-2020-key-vendors-trends-analysis-segmentation-forecast-to-2025-2020-10-09Based on the disease type, canine leishmaniasis management market is segmented into the following:Visceral leishmaniasisCutaneous leishmaniasisMucocutaneous leishmaniasis Based on the route of administration, canine leishmaniasis management market is segmented into the following:OralParenteralTopical Based on the distribution channel, canine leishmaniasis management market is segmented into the following:Veterinary clinicsVeterinary pharmaciesOnline pharmaciesNGO’sOthers Global canine leishmaniasis management market is in the developing stage with several international players are actively involved in the development of formulations for the treatment and prevention of canine leishmaniasis.Similarly, US Food and Drug Administration scientists are working with India and Brazil scientists for the development of a non-virulent vaccine to treat visceral leishmaniasis in canines.Europe, North America, Asia Pacific, Middle East and Africa, and Latin America.
The food and drug administration in the United States approved Bremelanotide to treat women’s sexual health problems like low sexual desire in women before menopause.So bremelanotide is used to treat generalized hypoactive sexual desire disorder or acquired hypoactive sexual desire disorder.Bremelanotide is sold under the name Vyleesi.Hypoactive sexual desire disorder (HSDD) is a condition that is marked not only by low sexual desire but also by distress, relationship difficulties, mental health conditions, etc.
Midwestern Pet Foods has expanded a previously announced recall of dog and cat food over the potentially high levels of a toxin produced by a naturally-occurring mold. This expanded recall covers all cat and dog food that has corn as an ingredient that expires on or before July 9, 2022. According to a separate alert from the FDA, more than … Continue reading
4
More than 10,000 containers of ice cream have been recalled in multiple US states over the risk of contamination, according to a recall recently highlighted by the FDA. The issue is the potential for small pieces of metal in the ice cream, with the recall noting that the metal pieces are from filling equipment parts. The recall comes from Weis … Continue reading
7
Maybe not on the wrist, but ear and finger... maybe a pulse oximeter device?
6
Data describing controversial supplement ractopamine didn’t render online A website that was supposed to offer real time tracking of pork imports to Taiwan has highlighted regional tensions.…
10
Quell 2.0 is a pain relief device approved by the Food and Drug Administration (FDA) for chronic pain relief.The device is a TENS unit that sends pulses to the spinal cord that induces the brain to release endorphins, the chemical which kills pain.So let’s take a brief overview of the Quell 2.0 Wearable Pain Relief Device.DesignThe device is smaller, thinner, and lighter than the previous model.Overall it looks fine.FeaturesThe device is compatible with iOS and Android, so you can use the Quell app on your smartphone, whether it’s Android or iOS.Whatever data you see on the app is collected by the device over a day, a month, or even more than three months.Well, the Quell 2.0 Wearable Pain Relief Device is not able to assess or measure your pain, so you will have to select your pain level from 0-10 in different conditions, like while sleeping or when you are active.Once you are done with the pain level selection, the device will automatically alter its intensity to give you more relief.Battery LifeAs the size of the Quell 2.0 Wearable Pain Relief Device is smaller than the previous model, hence its battery size has also got reduced.
3
The practice isn't currently supported by adequate scientific evidence, the FDA warned, and "may ultimately be counterproductive to public health."
5
According to KD  Market Insights the research report on the global Healthcare Robotics market provides detailed analysis of market sizing and forecasting of the market covering the market drivers, challenges, opportunity analysis, and trends, along with various key insights in the global market.The market research report also focuses on the analysis of the market value chain & supply chain for the market.The market for Healthcare Robotics is projected to reach at a noteworthy value by the end of 2025.Over the past years, the market for Healthcare Robotics has grown at a substantial rate and is expected to represent a lucrative growth over the forecast period.The study on global Healthcare Robotics market covers the key market growth indicators along with macroeconomic indicators for different segments & regions.Also, the research includes facts & figures which are related to the macroeconomic indicators that are estimated to drive the market growth globally.To Get More insights into the Market, Access sample of this report - https://www.kdmarketinsights.com/sample/6821The growth of this market is attributed towards major relying factors including increasing automation technologies, increase in funding and investment for medical robot research and market, the issuance of IPOs by medical robot companies, patient preference for minimally invasive surgeries, growth in the geriatric population, growing disabilities in humans, supply shortage of medical professionals, Food and Drug Administration (FDA) approval of critical surgeries and government backing for the healthcare market.Furthermore, the detailed analysis of porter’s five forces determines, the buyers bargaining power, suppliers bargaining power, the threat of new entrants, the threat of substitutes, and degree of competition in the global Healthcare Robotics market.In addition, the market research report plays an important role for the investors, stakeholders, distributors, manufacturers, and suppliers, since it provides a comprehensive analysis to understand the growth strategies.Key Segments Covered in the Global Healthcare Robotics Market:Market Forecast Analysis for 2019-2025Growth Drivers & Barriers, Market Trends, Market Opportunities, Porter’s Five Forces Analysis, Trade AnalysisMarket Overview, Industry Development, Market Maturity, Value Chain AnalysisImpact Analysis of Coronavirus Disease (COVID-19)Regional & Country Level AnalysisMarket Segment Trend and ForecastMarket Analysis and Various RecommendationsKey Market Driving FactorsCompetitive Landscape: Company Market Share & Market Positioning, Company Profiling, Recent Industry News.Segment Information:The market research report on the global Healthcare Robotics market provides a strategic analysis of multiple segmentation, covering all the important information related to the market.
Drug industry analysts predict how 2021 will play out for Pfizer, Moderna, and the global market for COVID-19 mRNA coronavirus vaccines.
7
DxTerity’s saliva-based at-home COVID-19 test, the first of its kind to get FDA authorization, is now available to buy directly from Amazon, the company has announced. The test kit is shipped to the recipient’s home, where the sample is collected, packaged, and shipped back to the company’s lab for testing. Testing in the US has become more readily available, at … Continue reading
7
More

Top